Member Info for Pharma3

Fantastic top of my head utilisation.👍😁

Doxorubicin worth 2.7b p/a in 2026.

That’s only between the ages of 30-60yrs old..

Pro dox can deliver to all ages…

2.7+b p/a x 8.3 industry multiplier - 22b for one drug..

And Avacta have a pipeline of drugs 10-14…..

What is this really worth?

If you do the maths it’s over 100b ex china

But let give a 50% reduction for the hell of it..

50-60b👍

Haha Timster! Love it

With a list price of $22,600 when administered every six weeks, Keytruda is now the top-selling drug in the world. Analysts, according to FactSet, expect sales to peak at $33.3 billion in 2027.

Timmy your such a knee slapper

2.5 hours back to port… send me your email I’ll send you the game fish

0430 start

You couldn’t afford to go abroad so you went scilly isles.. how’s the mermaid pub.. I own it doggy!

I thought it was a decent question but the peeps who think they own the board are tiny tiny little fish.. as watching says….explain how goose has 12 likes and watching has 2..

I’m in a wind up mood after a long day fishing for dorado on the Baja coast..

your 52,000 shares will come to fruitation watching but your breath stinks

1.1m shares here.. cheers

When it gets personal it shows the desperation…trot along pal

Anxiety is kicking in there watching… peeps like yourself are fully loaded and desperate… lie down

Agreed Goose

Thinking the same VS

Obviously H2…

It’s getting exciting

Just curious what peeps are thinking..

we deserve one soon.. it’s been a while for an update of trails and how they are going… they know what they have!

When are you professionals expecting the next update RNS?

And what do you think it will be?

2weekly trials? Sale of the DX Division?

I’ll wait another 12 months for £15+.

It could happen tomorrow, next week, or in a couple of months..May top slice a little..

kids ISA’s are full.😉

You on the Pop Timster? 🤣

Regarding R&D series, episode 4

As important as our science is at #AVCT, ensuring the team continues to excel is just as important to our success. A key to success with platform tech is consistent learning in the labs that is informed by our clinical data. Meet our team here👇🏻

#LetsDoThis

#PeptidesCreateHope